Cellectis S.A.
CMVLF
$4.50
-$0.54-10.71%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 110.30% | 56.97% | |||
| Total Other Revenue | 35.60% | 6.99% | |||
| Total Revenue | 104.27% | 51.26% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 104.27% | 51.26% | |||
| SG&A Expenses | 2.56% | 8.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 59.26% | 11.27% | |||
| Total Operating Expenses | 4.83% | 6.00% | |||
| Operating Income | 183.88% | 32.40% | |||
| Income Before Tax | 102.48% | -30.94% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 102.48% | -30.94% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 102.48% | -30.94% | |||
| EBIT | 183.88% | 32.40% | |||
| EBITDA | 272.86% | 41.96% | |||
| EPS Basic | 102.46% | -32.60% | |||
| Normalized Basic EPS | 102.47% | -32.63% | |||
| EPS Diluted | 102.46% | -32.60% | |||
| Normalized Diluted EPS | 102.40% | -32.63% | |||
| Average Basic Shares Outstanding | 1.44% | -1.25% | |||
| Average Diluted Shares Outstanding | 2.84% | -1.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||